Director Svetlana Dey bought 12,500 shares of BJDX at $2.00 on 2026-03-14 via private placement; stock now $1.72.
Svetlana Dey, a Director, purchased 12,500 shares at $2.00 for a total value of $25,000.00 on 2026-03-14, raising her stake to 12,501 shares from 1 share pre-transaction. However, this transaction is a private placement, not a discretionary open-market purchase, and therefore should not be interpreted as a buying signal driven by insider conviction. The current stock price of $1.72 sits -89.7% from the 52-week high of $16.68 and is down 14.0% over the past 30 days, while Bluejay Diagnostics' latest quarter shows a loss of $-1.9M on revenue of $249.0K, with a market cap of only $1.8M. The company remains unprofitable and severely distressed, making this directive-participation transaction a structural necessity rather than a positive signal about near-term prospects.